Literature DB >> 22555653

Transesophageal echocardiography and intraoperative phlebotomy during surgical repair of coarctation of aorta in a patient with atrial septal defect, moderately severe mitral regurgitation and severe pulmonary hypertension.

Praveen Kumar Neema1, Subrata K Singha, S Manikandan, Ramesh Chandra Rathod.   

Abstract

Acute left ventricular (LV) or right ventricular (RV) dysfunction during repair of coarctation of aorta (CoA) is rare. Well-developed collateral circulation between branches of both the subclavian arteries (SCAs) and upper descending thoracic aorta decompress LV and prevents acute rise in afterload. An adult patient presented for CoA repair. On chest X-ray, rib notching was not seen. Magnetic Resonance Imaging showed about 7 mm long CoA distal to the origin of left common carotid artery. Reconstruction images of distal arch and descending thoracic aorta showed origin of both the SCAs from CoA segment. Transthoracic echocardiography showed 1.3 cm atrial septal defect (ASD), left to right shunt, moderately severe mitral regurgitation (MR), dilated RV, and severe pulmonary artery hypertension (PH). During cardiac catheterization, the peak gradient across CoA was 60 mmHg. On aortic-root angiography, both the common carotids and the distal arch opacified simultaneously, the CoA segment and the distal aorta opacified a little later. Both the SCAs were filling retrograde. A unique anatomy in which aortic-clamping proximal to CoA and both the SCAs would increase flow to spinal-cord as clamping of the SCAs will stop stealing of blood into the CoA but potentially increase LV afterload, MR, left to right shunt across ASD and RV volume and pressure load depending on the magnitude of flow across the CoA. The increases in LV afterload, MR, and RV afterload and volume overload were managed by controlled phlebotomy and fine-tuned by manipulating inhaled isoflurane concentration whereas the Transesophageal echocardiography (TEE) monitored and guided the management.

Entities:  

Mesh:

Year:  2012        PMID: 22555653     DOI: 10.1007/s10877-012-9363-z

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  7 in total

1.  Hemodynamic effects of isovolemic hemodilution during descending thoracic aortic cross clamping and lower torso reperfusion.

Authors:  L F Poli de Figueiredo; M Mathru; W Tao; D Solanki; T Uchida; G C Kramer
Journal:  Surgery       Date:  1997-07       Impact factor: 3.982

2.  Infrarenal abdominal aortic aneurysm repair in presence of coronary artery disease: optimization of myocardial stress by controlled phlebotomy.

Authors:  Praveen Kumar Neema; Arun Vijayakumar; S Manikandan; Ramesh Chandra Rathod
Journal:  Ann Card Anaesth       Date:  2009 Jul-Dec

Review 3.  Venous function and central venous pressure: a physiologic story.

Authors:  Simon Gelman
Journal:  Anesthesiology       Date:  2008-04       Impact factor: 7.892

4.  Perioperative implications of retrograde flow in both the subclavian arteries in an adult undergoing surgical repair of coarctation of aorta.

Authors:  Praveen Kumar Neema; Sethuraman Manikandan; Narendra Bodhey; Arun Kumar Gupta
Journal:  Interact Cardiovasc Thorac Surg       Date:  2010-11-30

Review 5.  The pathophysiology of aortic cross-clamping and unclamping.

Authors:  S Gelman
Journal:  Anesthesiology       Date:  1995-04       Impact factor: 7.892

6.  Monitoring with two-dimensional transesophageal echocardiography. Comparison of myocardial function in patients undergoing supraceliac, suprarenal-infraceliac, or infrarenal aortic occlusion.

Authors:  M F Roizen; P N Beaupre; R A Alpert; P Kremer; M K Cahalan; N Shiller; Y J Sohn; R Cronnelly; F W Lurz; W K Ehrenfeld
Journal:  J Vasc Surg       Date:  1984-03       Impact factor: 4.268

7.  Right arm ischemia following intentional stent-graft coverage of an anomalous right subclavian artery.

Authors:  Matthew Waltham; Ves Agrawal; Leigh Bowman; Clifford Hughes; Geoffrey H White
Journal:  J Endovasc Ther       Date:  2005-02       Impact factor: 3.487

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.